Skip to main content

MEDICINOVA INC

For the period ended Dec 31, 2024. Filed Feb 19, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 19, 2025

MNOV$1.40-4.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 8. Consolidated Statements of Cash Flows

CONSOLIDATED STATEM ENTS OF CASH FLOWS

Years ended December 31,
20242023
Operating activities:
Net loss$(11,049,549)$(8,571,516)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash stock-based compensation1,191,740710,710
Depreciation and amortization21,07720,295
Non-cash interest on investments—(346,390)
Loss on disposal of investments—448,903
(Gain) loss on disposal of property and equipment(198)472
Change in carrying amount of right-of-use asset173,522194,502
Changes in assets and liabilities:
Prepaid expenses and other assets(491,005)287,628
Accounts payable, accrued liabilities and other liabilities(312,347)19,238
Operating lease liabilities(176,204)(194,880)
Net cash used in operating activities(10,642,964)(7,431,038)
Investing activities:
Proceeds from disposal of investments—39,929,015
Proceeds from sale of property and equipment198—
Acquisitions of property and equipment(895)(21,299)
Net cash provided by (used in) investing activities(697)39,907,716
Effect of exchange rate changes on cash and cash equivalents3,95717,271
Net change in cash and cash equivalents(10,639,704)32,493,949
Cash and cash equivalents, beginning of year50,999,44218,505,493
Cash and cash equivalents, end of year$40,359,738$50,999,442
Supplemental disclosure of cash flow information:
Right-of-use asset obtained in exchange for operating lease liability$42,281$139,001
Change in carrying amount of right-of-use asset due to termination of lease$79,229$—
Income taxes paid$5,042$3,667
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.